Stereotaxis has announced that it has received US Food and Drug Administration (FDA) 510(k) clearance for the Synchrony system, which is designed to “digitise and modernise” the interventional cath lab.
“We have long recognised that seamless remote connectivity and collaboration for our EP [electrophysiology] labs could be very beneficial,” commented Mauricio Arruda (Case Western Reserve University School of Medicine, Cleveland, USA). “We are particularly interested in being early pioneers of Synchrony and SynX, and look forward to demonstrating that intraoperative collaboration enhances our ability to provide the best patient care and train the next generation of physicians.”
As detailed in a press release from Stereotaxis, Synchrony’s 55-inch 4K ultra-high-definition display consolidates the viewing and control of all disparate systems in the lab, offering an enhanced procedure experience with custom layouts, streamlined workflows, an intuitive user interface, and a decluttered environment. Stereotaxis also claims that Synchrony digitises video streams with full fidelity and ultra-low latency, offering crystal-clear visualisation—and its architecture allows obsolescence protection for labs as new technologies are introduced in the future.
Additionally, Synchrony is made available with SynX—a cloud-based US Health Insurance Portability and Accountability Act (HIPAA)- and EU General Data Protection Regulation (GDPR)-compliant app that allows for secure remote connectivity, collaboration, recording and monitoring of the cath lab.
“We are excited by this technology and the opportunity to be among the first to modernise our cath labs with Synchrony and SynX when the Richard M Schulze Surgical and Critical Care Center at Abbott Northwestern Hospital [Minneapolis, USA] opens in late August,” said Daniel Melby (Allina Health Minneapolis Heart Institute, Minneapolis, USA). “Our cardiology labs have become increasingly busy and complex environments, accentuating the value of technology that enhances procedure workflow, improves lab efficiency and encourages collaboration.”
“In my role managing the technology across our EP labs and advising labs across the country, I have significant experience with various interventional lab display offerings,” added Matthew Dare (St David’s Medical Center, Austin, USA). “The underlying hardware and software architecture of Synchrony and SynX is far beyond what anyone else has developed. It promises a better intraoperative experience for physicians and nurses, improved equipment reliability and maintenance, and attractive tools for managing a cardiovascular programme with remote monitoring, collaboration and recordings.”
“Synchrony and SynX are central to our digital surgery efforts to modernise the interventional lab with enhanced workflow, remote connectivity and smart AI [artificial intelligence] capabilities,” said Stereotaxis chairman and chief executive officer (CEO) David Fischel. “The technology improves the robotic cockpit, and will be critical in supporting robotic efforts for remote long-distance procedures and automated catheter navigation. The opportunity is much broader than robotic labs, as we believe all cath labs stand to benefit from improved workflow, connectivity, and collaboration.”
